Page 257 - Tata_Chemicals_yearly-reports-2020-2021
P. 257
Integrated Report Statutory Reports Financial Statements
1-59 60-146 Consolidated
(ii) Movement in credit impaired ` in crore
Year ended Year ended
March 31, 2021 March 31, 2020
Balance at the beginning of the year 87.36 91.43
Credit impaired pertaining to discontinued operations (note 36) - (11.43)
Provision during the year 5.77 11.24
Reversal during the year (2.12) (4.29)
Exchange fluctuation (0.02) 0.41
Balance at the end of the year 90.99 87.36
(iii) Trade receivables have been offered as security against working capital facilities provided by the bank.
15. Cash and cash equivalents and other bank balances
` in crore
As at As at
March 31, 2021 March 31, 2020
Cash and cash equivalents:
(a) Balance with banks 263.19 489.65
(b) Cash on hand 0.05 0.10
(c) Deposit accounts (with original maturity less than 3 months) 426.10 764.51
Cash and cash equivalents as per Statement of Cash Flow 689.34 1,254.26
Other bank balances:
(a) Earmarked balances with banks 20.20 22.32
(b) Deposit accounts
(other than (c) above, with maturity less than 12 months from the Balance Sheet date) 701.47 802.94
721.67 825.26
Footnote:
(i) Non cash transactions
The Group has not entered into non cash investing and financing activities.
16. Equity share capital
As at March 31, 2021 As at March 31, 2020
No of shares ` in crore No of shares ` in crore
(a) Authorised:
Ordinary shares of ` 10 each 27,00,00,000 270.00 27,00,00,000 270.00
(b) Issued :
Ordinary shares of ` 10 each 25,48,42,598 254.84 25,48,42,598 254.84
(c) Subscribed and fully paid up:
Ordinary shares of ` 10 each 25,47,56,278 254.76 25,47,56,278 254.76
(d) Forfeited shares:
Amount originally paid-up on forfeited shares 86,320 0.06 86,320 0.06
254.82 254.82
255